전문정보검색
| No | 제목 / 내용 |
|---|---|
| 1 |
CC-001 An unusual cause of dyspepsia Surgery, Stomach, Pylorus, Medicine, Gastrointestinal disease, Fistula, Duodenum, Cystic duct, Common bile duct, Cholecystectomy |
| 2 |
The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-B Placebo-controlled study, Oncology, Neutropenia, Myeloid leukemia, Medicine, Internal medicine, Hematopoietic stem cell transplantat |
| 3 |
Perfil de aço Pre-Galvanized C Canal para Estrutura de aço (SSW-CC-001) |
| 4 |
CC-122 DLBCL-001: Phase Ib Study of CC-122 Plus Rituximab in Patients with Chemo-Refractory Diff Rituximab, Refractory Diffuse Large B-Cell Lymphoma, Neutropenia, Medicine, In patient, Febrile neutropenia, Extremity Pain, Diffuse |
| 5 |
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma Background: CC chemokine receptor-7 (CCR7), which plays a critical role in the migration of activated dendritic cells to regional lymp |
| 6 |
Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma BACKGROUND Avadomide (CC-122) is a novel oral cereblon-modulating agent with promising activity in non-Hodgkin lymphoma. We aimed to e |
| 7 |
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) m Older patients with acute myeloid leukemia (AML) have worse rates of complete remission and shorter overall survival than younger pati |
| 8 |
Health-related quality of life (HRQoL) in the phase III QUAZAR-AML-001 trial of CC-486 as mainte Relapse risk, Placebo, Oncology, Myeloid leukemia, Medicine, Maintenance therapy, Internal medicine, Induction chemotherapy, Health |
| 9 |
CC-486 Prolongs Survival for Patients with Acute Myeloid Leukemia (AML) in Remission after Inten Oncology, Myeloid leukemia, Medicine, Internal medicine, Intensive chemotherapy, Disease |
| 10 |
CC-486 Improves Overall Survival (OS) and Relapse-Free Survival (RFS) for Patients with Acute My Relapse free survival, Overall survival, Oncology, Myeloid leukemia, Medicine, Internal medicine, Intensive chemotherapy, First remi |